chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Pain on the sides; Ache on Sunday night / pain on the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain on the sides) and VACCINATION SITE PAIN (Ache on Sunday night / pain on the site of injection) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN (Pain on the sides) and VACCINATION SITE PAIN (Ache on Sunday night / pain on the site of injection). At the time of the report, PAIN (Pain on the sides) and VACCINATION SITE PAIN (Ache on Sunday night / pain on the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: TCR added with no new information.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Faeces soft, Gastritis, Muscle tightness
Clinical narrative: gastritis; Bowels were soft not formed; queasiness; threw up; stomach ache; tight muscles; discomfort in the stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach), GASTRITIS (gastritis) and FAECES SOFT (Bowels were soft not formed) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L2O1) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach) and VOMITING (threw up). On an unknown date, the patient experienced GASTRITIS (gastritis), FAECES SOFT (Bowels were soft not formed) and NAUSEA (queasiness). The patient was treated with PROBIOTICS NOS ongoing since an unknown date at a dose of 1 dosage form and GLYCYRRHIZA GLABRA ROOT (DGL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach), GASTRITIS (gastritis), FAECES SOFT (Bowels were soft not formed), VOMITING (threw up) and NAUSEA (queasiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included aloe juice, Pepto, sucking ginger candies.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter's Email address added.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: gastritis; Bowels were soft not formed; queasiness; threw up; stomach ache; tight muscles; discomfort in the stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach), GASTRITIS (gastritis) and FAECES SOFT (Bowels were soft not formed) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L2O1) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach) and VOMITING (threw up). On an unknown date, the patient experienced GASTRITIS (gastritis), FAECES SOFT (Bowels were soft not formed) and NAUSEA (queasiness). The patient was treated with PROBIOTICS NOS ongoing since an unknown date at a dose of 1 dosage form and GLYCYRRHIZA GLABRA ROOT (DGL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), MUSCLE TIGHTNESS (tight muscles), ABDOMINAL DISCOMFORT (discomfort in the stomach), GASTRITIS (gastritis), FAECES SOFT (Bowels were soft not formed), VOMITING (threw up) and NAUSEA (queasiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment details included aloe juice, Pepto, sucking ginger candies.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter's Email address added.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site mass, Pain, Rash macular, Tenderness
Clinical narrative: sore arm; tenderness; Injection site had a little red small spot; little lump under skin; Red like 3 inches around little spot; little warm area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin) and RASH MACULAR (Red like 3 inches around little spot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin), RASH MACULAR (Red like 3 inches around little spot) and VACCINATION SITE WARMTH (little warm area). At the time of the report, PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin), RASH MACULAR (Red like 3 inches around little spot) and VACCINATION SITE WARMTH (little warm area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient put ice and week after the lump dissipated and red gone away.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: sore arm; tenderness; Injection site had a little red small spot; little lump under skin; Red like 3 inches around little spot; little warm area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin) and RASH MACULAR (Red like 3 inches around little spot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin), RASH MACULAR (Red like 3 inches around little spot) and VACCINATION SITE WARMTH (little warm area). At the time of the report, PAIN (sore arm), TENDERNESS (tenderness), ERYTHEMA (Injection site had a little red small spot ), INJECTION SITE MASS (little lump under skin), RASH MACULAR (Red like 3 inches around little spot) and VACCINATION SITE WARMTH (little warm area) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient put ice and week after the lump dissipated and red gone away.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: It is harder than normal skin around the inoculation site; Itchy around the inoculation site; Noticed a red spot around the innoculation site; It has a rash texture; A little tender to the touch, but not painful at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (It is harder than normal skin around the inoculation site), VACCINATION SITE PRURITUS (Itchy around the inoculation site), VACCINATION SITE PAIN (A little tender to the touch, but not painful at injection site), VACCINATION SITE ERYTHEMA (Noticed a red spot around the innoculation site) and VACCINATION SITE RASH (It has a rash texture) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 01-Sep-2020. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) from 01-Sep-2020 to an unknown date, MONTELUKAST SODIUM (SINGULAIR) from 01-Sep-2020 to an unknown date and BUDESONIDE (PULMICORT FLEXHALER) from 01-Sep-2020 to an unknown date for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (A little tender to the touch, but not painful at injection site). On 02-Feb-2021, the patient experienced VACCINATION SITE INDURATION (It is harder than normal skin around the inoculation site), VACCINATION SITE PRURITUS (Itchy around the inoculation site), VACCINATION SITE ERYTHEMA (Noticed a red spot around the innoculation site) and VACCINATION SITE RASH (It has a rash texture). At the time of the report, VACCINATION SITE INDURATION (It is harder than normal skin around the inoculation site), VACCINATION SITE PRURITUS (Itchy around the inoculation site) and VACCINATION SITE PAIN (A little tender to the touch, but not painful at injection site) outcome was unknown and VACCINATION SITE ERYTHEMA (Noticed a red spot around the innoculation site) and VACCINATION SITE RASH (It has a rash texture) had resolved with sequelae.            On 02 Feb 2021, eight days after the vaccination, patient noticed a red spot. Patient was recovered with slight discolororation on arm which was approximately 2" by 4". No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Added reporter information, patient demographics, historical condition, vaccine information, outcome of the events vaccination site erythema and vaccination site rash and causality was updated.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Body temperature, Headache, Hyperhidrosis
Clinical narrative: Upset stomach; Swatting a lot almost her bedsheet was wait; Tempera100.2C; Joint pain; Extreme headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache). At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 100.2 (Inconclusive) 100.2.         Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Upset stomach; Swatting a lot almost her bedsheet was wait; Tempera100.2C; Joint pain; Extreme headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache). At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach), HYPERHIDROSIS (Swatting a lot almost her bedsheet was wait), PYREXIA (Tempera100.2C), ARTHRALGIA (Joint pain) and HEADACHE (Extreme headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Body temperature: 100.2 (Inconclusive) 100.2.         Action taken with mRNA-1273 in response to the events was not applicable.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Hypersensitivity, Illness, Pain in extremity, Pruritus
Clinical narrative: painful; The groin area is all blistered; slept most of Sunday, which is not like him; pustules; itchy; he's in misery; severe hypersensitivity subcutaneous rash; rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,; rash around the injection site, just on his left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), RASH PUSTULAR (pustules) and PRURITUS (itchy) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), RASH PUSTULAR (pustules), PRURITUS (itchy), ILLNESS (he's in misery), HYPERSENSITIVITY (severe hypersensitivity subcutaneous rash), RASH (rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,) and VACCINATION SITE RASH (rash around the injection site, just on his left arm). At the time of the report, PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), PRURITUS (itchy), ILLNESS (he's in misery), HYPERSENSITIVITY (severe hypersensitivity subcutaneous rash), RASH (rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,) and VACCINATION SITE RASH (rash around the injection site, just on his left arm) outcome was unknown and RASH PUSTULAR (pustules) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment medication included antibiotics and antifungal cream for the groin area, but they stopped using it.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Event was added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pustular, Somnolence, Vaccination site rash
Clinical narrative: painful; The groin area is all blistered; slept most of Sunday, which is not like him; pustules; itchy; he's in misery; severe hypersensitivity subcutaneous rash; rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,; rash around the injection site, just on his left arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), RASH PUSTULAR (pustules) and PRURITUS (itchy) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), RASH PUSTULAR (pustules), PRURITUS (itchy), ILLNESS (he's in misery), HYPERSENSITIVITY (severe hypersensitivity subcutaneous rash), RASH (rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,) and VACCINATION SITE RASH (rash around the injection site, just on his left arm). At the time of the report, PAIN IN EXTREMITY (painful), BLISTER (The groin area is all blistered), SOMNOLENCE (slept most of Sunday, which is not like him), PRURITUS (itchy), ILLNESS (he's in misery), HYPERSENSITIVITY (severe hypersensitivity subcutaneous rash), RASH (rash spread on his left arm where the shot was, where his elbow bends, his forearms, back of his arms,) and VACCINATION SITE RASH (rash around the injection site, just on his left arm) outcome was unknown and RASH PUSTULAR (pustules) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. Treatment medication included antibiotics and antifungal cream for the groin area, but they stopped using it.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Event was added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site pain
Clinical narrative: Dizzy  dizzy spells; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy  dizzy spells) and VACCINATION SITE PAIN (Sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included ALLERGY MEDICATION.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 28-Jan-2021, the patient experienced DIZZINESS (Dizzy  dizzy spells). At the time of the report, DIZZINESS (Dizzy  dizzy spells) and VACCINATION SITE PAIN (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Con meds include blood pressure and anxiety pills.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN for an unknown indication.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different). On 25-Jan-2021, SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. The patient noticed he had gold streaks in his hand later the next night. The patient strongly believed the condition was caused by something completely different.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Event details updated.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache, Pain in extremity, Vaccination site pain
Clinical narrative: chest burning sensation; arm and shoulder  pain; arm sore left arm (injection site); headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest burning sensation), PAIN IN EXTREMITY (arm and shoulder  pain), VACCINATION SITE PAIN (arm sore left arm (injection site)) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced CHEST PAIN (chest burning sensation), PAIN IN EXTREMITY (arm and shoulder  pain), VACCINATION SITE PAIN (arm sore left arm (injection site)) and HEADACHE (headache). At the time of the report, CHEST PAIN (chest burning sensation), PAIN IN EXTREMITY (arm and shoulder  pain), VACCINATION SITE PAIN (arm sore left arm (injection site)) and HEADACHE (headache) had resolved.            No treatment information was provided.  No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Updated events outcome as recovered/resolved.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Patient is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Jun-2021. On 29-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant). On 29-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Patient is pregnant) had resolved.            No Concomitant medications provided. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Feb-2021: Upon internal review on 21-Jul-2021, patient, events, analysis and regulatory reports tabs were updated.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nervousness, Pain in extremity, Palpitations
Clinical narrative: lightheadedness, dizzy, felt like she was going to fall; shaky; Afib started up again (heart was racing); arm hurts; head hurt; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheadedness, dizzy, felt like she was going to fall), NERVOUSNESS (shaky), PALPITATIONS (Afib started up again (heart was racing)), PAIN IN EXTREMITY (arm hurts) and HEADACHE (head hurt) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced DIZZINESS (lightheadedness, dizzy, felt like she was going to fall), NERVOUSNESS (shaky), PALPITATIONS (Afib started up again (heart was racing)), PAIN IN EXTREMITY (arm hurts) and HEADACHE (head hurt). At the time of the report, DIZZINESS (lightheadedness, dizzy, felt like she was going to fall), NERVOUSNESS (shaky), PALPITATIONS (Afib started up again (heart was racing)), PAIN IN EXTREMITY (arm hurts) and HEADACHE (head hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication included acetaminophen.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Running a fever of 103; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (Running a fever of 103) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced PYREXIA (Running a fever of 103). At the time of the report, PYREXIA (Running a fever of 103) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Based on the current available information and temporal association between the use of the product and the onset date of the event of pyrexia, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event of pyrexia, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Influenza like illness, Influenza virus test, Myalgia, Nodule
Clinical narrative: COVID rash; mosquito-bite-like bump on back of leg; Itchy rash on back of leg, spreading/rash isolated to back of leg; Body aches; fever; bad flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (bad flu-like symptoms), NODULE (mosquito-bite-like bump on back of leg), RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg), RASH (COVID rash) and MYALGIA (Body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included SIMVASTATIN for High cholesterol.   On 04-Jan-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (bad flu-like symptoms), MYALGIA (Body aches) and PYREXIA (fever). On 03-Feb-2021, the patient experienced NODULE (mosquito-bite-like bump on back of leg) and RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg). On 22-Feb-2021, the patient experienced RASH (COVID rash). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 05-Feb-2021, MYALGIA (Body aches) and PYREXIA (fever) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (bad flu-like symptoms) and NODULE (mosquito-bite-like bump on back of leg) outcome was unknown and RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg) and RASH (COVID rash) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 degree. On an unknown date, Influenza virus test: Negative. On an unknown date, SARS-CoV-2 test: Negative.         Treatment medications included steroids, anti-virals and anti-itch cream.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Patient demographic information was updated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Rash pruritic, SARS-CoV-2 test
Clinical narrative: COVID rash; mosquito-bite-like bump on back of leg; Itchy rash on back of leg, spreading/rash isolated to back of leg; Body aches; fever; bad flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (bad flu-like symptoms), NODULE (mosquito-bite-like bump on back of leg), RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg), RASH (COVID rash) and MYALGIA (Body aches) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included SIMVASTATIN for High cholesterol.   On 04-Jan-2021 at 7:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021 at 2:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (bad flu-like symptoms), MYALGIA (Body aches) and PYREXIA (fever). On 03-Feb-2021, the patient experienced NODULE (mosquito-bite-like bump on back of leg) and RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg). On 22-Feb-2021, the patient experienced RASH (COVID rash). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 05-Feb-2021, MYALGIA (Body aches) and PYREXIA (fever) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (bad flu-like symptoms) and NODULE (mosquito-bite-like bump on back of leg) outcome was unknown and RASH PRURITIC (Itchy rash on back of leg, spreading/rash isolated to back of leg) and RASH (COVID rash) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 degree. On an unknown date, Influenza virus test: Negative. On an unknown date, SARS-CoV-2 test: Negative.         Treatment medications included steroids, anti-virals and anti-itch cream.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Patient demographic information was updated.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site haemorrhage
Clinical narrative: Significant amount of blood on the Band-Aid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-Feb-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid). On 05-Feb-2021, VACCINATION SITE HAEMORRHAGE (Significant amount of blood on the Band-Aid) had resolved.            No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the event, therefore action taken with the drug in the event is not applicable After second dose a gauze and then a band aid is placed on his arm.There was a significant amount of blood on the Band-Aid when he got up the next morning.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: TCR is attached on 24-June in which no new information.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Feeling hot
Clinical narrative: hot skin feeling; low abdominal pain; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (hot skin feeling) and ABDOMINAL PAIN LOWER (low abdominal pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced FEELING HOT (hot skin feeling) and ABDOMINAL PAIN LOWER (low abdominal pain). At the time of the report, FEELING HOT (hot skin feeling) and ABDOMINAL PAIN LOWER (low abdominal pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received as Telephone contact report contains event onset dates and updated outcome of the events. Event outcome updated from unknown to recovered.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Pain
Clinical narrative: maybe a little bit of arm pain; nausea; about to die; worst body aches of her life; worst headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (about to die), PAIN IN EXTREMITY (maybe a little bit of arm pain), PAIN (worst body aches of her life), HEADACHE (worst headache) and FATIGUE (fatigue) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced FEELING ABNORMAL (about to die), PAIN (worst body aches of her life), HEADACHE (worst headache) and FATIGUE (fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (maybe a little bit of arm pain) and NAUSEA (nausea). At the time of the report, FEELING ABNORMAL (about to die), PAIN IN EXTREMITY (maybe a little bit of arm pain), PAIN (worst body aches of her life), HEADACHE (worst headache), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided by the reporter.  Treatment information was not provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: maybe a little bit of arm pain; nausea; about to die; worst body aches of her life; worst headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (about to die), PAIN IN EXTREMITY (maybe a little bit of arm pain), PAIN (worst body aches of her life), HEADACHE (worst headache) and FATIGUE (fatigue) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced FEELING ABNORMAL (about to die), PAIN (worst body aches of her life), HEADACHE (worst headache) and FATIGUE (fatigue). On an unknown date, the patient experienced PAIN IN EXTREMITY (maybe a little bit of arm pain) and NAUSEA (nausea). At the time of the report, FEELING ABNORMAL (about to die), PAIN IN EXTREMITY (maybe a little bit of arm pain), PAIN (worst body aches of her life), HEADACHE (worst headache), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Racing Heart beat; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Racing Heart beat) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced TACHYCARDIA (Racing Heart beat). At the time of the report, TACHYCARDIA (Racing Heart beat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19; A spontaneous report was received from a consumer concerning a 67-years-old  male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tested positive for covid-19.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013L20A) intramuscularly  in upper left deltoid for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced the event tested positive for covid-19.  Treatment details included Eli Lilly - Monoclonal antibody infusion.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of event, tested positive for covid-19 was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Feels terrible; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels terrible) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feels terrible). At the time of the report, FEELING ABNORMAL (Feels terrible) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Movement disorder, Pain, Pain in extremity
Clinical narrative: My arm was sore; Excruciating pain; Can't put it behind me; Aching in the left shoulder joint; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm was sore), PAIN (Excruciating pain), MOVEMENT DISORDER (Can't put it behind me) and ARTHRALGIA (Aching in the left shoulder joint) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ARTHRALGIA (Aching in the left shoulder joint). On an unknown date, the patient experienced PAIN IN EXTREMITY (My arm was sore), PAIN (Excruciating pain) and MOVEMENT DISORDER (Can't put it behind me). The patient was treated with ACETAMINOPHEN at a dose of UNK, q4h. At the time of the report, PAIN IN EXTREMITY (My arm was sore), PAIN (Excruciating pain), MOVEMENT DISORDER (Can't put it behind me) and ARTHRALGIA (Aching in the left shoulder joint) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: This case concerns an 81-year-old male with NS unexpected events of pain in extremity, pain and NS expected events of arthralgia and movement disorder.  Event onset with unknown latency after the first dose of mRNA-1273. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Nausea, Pain, Vomiting
Clinical narrative: body aches; loss of appetite; nausea; vomiting; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (body aches), DECREASED APPETITE (loss of appetite), NAUSEA (nausea) and VOMITING (vomiting) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy (Nuts, shellfish, dairy) and Environmental allergy. Concomitant products included CITALOPRAM for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (body aches), DECREASED APPETITE (loss of appetite), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, PAIN (body aches), DECREASED APPETITE (loss of appetite), NAUSEA (nausea) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient tested negative for covid-19 on 11-Jan-2021 and 13-jan-2021.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: report breastfeeding; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (report breastfeeding) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 041L20A) for COVID-19 vaccination.    MEDICAL HISTORY (Parent): The patient reported having given birth a week prior to her first vaccine.  Concurrent medical conditions included Maternal exposure during breast feeding.    MEDICAL HISTORY (Patient): No medical history was provided by reporter.  Concomitant products included ENOXAPARIN SODIUM (LOVENOX HP) for Anticoagulant therapy, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (report breastfeeding). At the time of the report, EXPOSURE VIA BREAST MILK (report breastfeeding) outcome was unknown. Not Provided
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Rash
Clinical narrative: Dizziness; Rash; Nausea; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), RASH (Rash) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (Dizziness), RASH (Rash) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness), RASH (Rash) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.; Reporter's Comments: .; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic, Vaccination site pain
Clinical narrative: rashes all over the body and they itch; rashes all over the body and they itch; Pain in the arm after getting the shot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rashes all over the body and they itch), RASH PRURITIC (rashes all over the body and they itch) and VACCINATION SITE PAIN (Pain in the arm after getting the shot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain in the arm after getting the shot). On 18-Jan-2021, the patient experienced RASH (rashes all over the body and they itch) and RASH PRURITIC (rashes all over the body and they itch). At the time of the report, RASH (rashes all over the body and they itch), RASH PRURITIC (rashes all over the body and they itch) and VACCINATION SITE PAIN (Pain in the arm after getting the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Rashes started a day or two later and they come and go. The patient had gone to different doctors and gotten different medications but it cleared for 2 days and it was back again.